Invitation to Press Conference: Alzheimer's Breakthrough - Live Webcast of Worldwide Press Conference

VIENNA, Austria, May 27, 2014 /PRNewswire/ --

AFFiRiS AG Presents Clinical Phase II Data 

Wednesday, 4 June 2014 

10.00 am CEST (Central European Summer Time) 

08.00 am UTC (Coordinated Universal Time)  

Live webcast link:  http://webtv.braintrust.at/affiris/2014-06-04/   

(A recording of the webcast will be available right after the press conference at the aforementioned link.)

AFFiRiS AG, Vienna, Austria will present final data of a clinical trial phase II of its proprietary Alzheimer's therapy. More than 300 patients were included in the international multi-centric clinical trial and significant effects have been observed.

Data will be presented by

Dr. Walter Schmidt, CEO & Co-founder AFFiRiS AG

Dr. Frank Mattner, CSO & Co-founder AFFiRiS AG

The conference will take place at the Vienna Marriott Hotel, Parkring 12a, 1010 Vienna, Room Sachsen Coburg at 10.00 am CEST. If you are unable to attend please visit the aforementioned web link for a live webcast of the press conference. An embedded message board will allow you to participate in the Q&A round. A recording of the conference will be made available at the following link immediately after the press conference: http://webtv.braintrust.at/affiris/2014-06-04/.

Should you wish for a (telephone) interview after the press conference please contact AFFiRiS' press agency PR&D (see below). Interview slots will be allocated strictly on a first come, first served policy.

Photos of the press conference will be available at 2 pm CEST (12 UTC) here: http://www.apa-fotoservice.at/galerie/5480

About AFFiRiS AG

Based on the company's own patent positions, AFFiRiS develops tailor-made peptide vaccines (and more) for Alzheimer's disease, Atherosclerosis, Parkinson's disease, diabetes and several other conditions with urgent requirement for new treatments and attractive market volumes. Alzheimer's is the current lead indication. AFFiRiS currently employs 100 highly-qualified staff at the Campus Vienna Biocenter in Vienna, Austria (http://www.affiris.com).

PR&D - Public Relations for Research & Education
Nina Honzik or Judith Sandberger
T +43-1-505-70-44
F +43-1-505-50-83
E [email protected] or [email protected]
Mariannengasse 8
1090 Vienna, Austria
http://www.prd.at

SOURCE AFFiRiS AG

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED